DEBIOPHARM INNOVATION FUND
Debiopharm Innovation Fund invests in digital health companies that have an impact on cancer, infectious diseases, and drug development. We are looking for ambitious entrepreneurs raising series A or B with clinically proven, transformative technologies that use AI and data to help patients. We do not invest in consumer wellness or workflow solutions. Our initial investment is typically $2-5M. Along with capital we bring deep pharma knowledge & networks and long-term commitment to help build value in your company. We are an evergreen investment fund of the pharmaceutical company Debiopharm based in Lausanne, Switzerland.
DEBIOPHARM INNOVATION FUND
Industry:
Venture Capital
Founded:
1979-01-01
Status:
Active
Contact:
418-650-3535
Email Addresses:
[email protected]
Technology used in webpage:
Apple Mobile Web Clips Icon Amazon ASP.NET IIS Amazon Virginia Region Java EE Lorem Ipsum WordPress 5.8 Apple Whitelist IIS 7
Similar Organizations
North East Technology Fund
North East Technology Fund is a venture capital firm invests in technology businesses.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-05-09 | Mika | Debiopharm Innovation Fund investment in Series A - Mika | 10 M EUR |
| 2022-03-30 | VivoSense | Debiopharm Innovation Fund investment in Series A - VivoSense | 25 M USD |
| 2022-03-22 | Nucleai | Debiopharm Innovation Fund investment in Series B - Nucleai | 33 M USD |
| 2022-01-13 | VeriSIM Life | Debiopharm Innovation Fund investment in Series A - VeriSIM Life | 15 M USD |
| 2021-11-09 | Mekonos | Debiopharm Innovation Fund investment in Series A - Mekonos | 25 M USD |
| 2021-02-18 | Carevive Systems | Debiopharm Innovation Fund investment in Series C - Carevive Systems | 18 M USD |
| 2020-11-20 | Voluntis | Debiopharm Innovation Fund investment in Post-IPO Equity - Voluntis | N/A |
| 2020-09-09 | Oncomfort | Debiopharm Innovation Fund investment in Series A - Oncomfort | 10 M EUR |
| 2020-07-07 | Nucleai | Debiopharm Innovation Fund investment in Series A - Nucleai | 8.5 M USD |
| 2020-02-13 | Carevive Systems | Debiopharm Innovation Fund investment in Series C - Carevive Systems | 14.96 M USD |